Perinatal outcomes of fetoscopic laser surgery for twin–twin transfusion syndrome in triplet pregnancy: cohort study, systematic review and meta‐analysis

• Published in: Ultrasound in obstetrics & gynecology 2022-07, Vol.60 (1), p.42-51
• Main Authors: Mustafa, H. J., Javinani, A., Krispin, E., Tadbiri, H., Shamshirsaz, A. A., Espinoza, J., Nassr, A. A., Donepudi, R., Belfort, M. A., SANZ Cortes, M., Harman, C., Turan, O. M.
• Format: Article
• Language: English
• Subjects: Birth; Cohort analysis; Data collection; DCTA; Demographic variables; dichorionic; fetoscopic laser; Fetuses; Gestational age; Gynecology; MCTA; Meta-analysis; monochorionic; Neonates; Obstetrics; Pregnancy; Premature birth; Survival; Systematic review; Transfusion; triamniotic; triplet; Triplets; TTTS
• ISSN: 0960-7692; 1469-0705
• DOI: 10.1002/uog.24887

ABSTRACT Objectives The aims of this study were to investigate the perinatal outcome of dichorionic triamniotic (DCTA) and monochorionic triamniotic (MCTA) triplet pregnancies complicated by twin–twin transfusion syndrome (TTTS) treated with fetoscopic laser photocoagulation (FLP) in two academic fetal centers, and to conduct a systematic review of previously published data to investigate perinatal survival in this targeted population. Methods The first part of the study was a retrospective cohort study of prospectively collected data of consecutive triplet pregnancies with TTTS that underwent FLP at two fetal treatment centers between 2012 and 2020. Demographic, preoperative and operative variables and postoperative outcome were collected. Perinatal outcomes were investigated. The second part of the study was a systematic review and meta‐analysis of studies evaluating the outcome of DCTA and/or MCTA triplet pregnancies, including our cohort study. PubMed, Web of Science and Scopus were searched from inception to September 2020. Primary outcomes were fetal survival (survival to birth), neonatal survival (survival to 28 days of age) and gestational age (GA) at birth. Results A total of 31 sets of triplets with TTTS managed with FLP were included in the cohort study. Of these, 24 were DCTA and seven were MCTA. There were no significant differences in preoperative and operative variables between the two groups. There were also no significant differences between groups in GA at delivery or perinatal survival rate, including fetal and neonatal survival of at least one triplet, at least two triplets and all three triplets. Nine studies, including our cohort study, were included in the systematic review (156 DCTA and 37 MCTA triplet pregnancies treated with FLP). The overall fetal and neonatal survival was 79% (95% CI, 75–83%) and 75% (95% CI, 71–79%), respectively, in DCTA cases and 74% (95% CI, 52–92%) and 71% (95% CI, 49–89%), respectively, in MCTA cases. The rate of preterm birth before 28 weeks and before 32 weeks' gestation was 14% (95% CI, 4–29%) and 61% (95% CI, 50–72%), respectively, in DCTA triplets and 21% (95% CI, 3–45%) and 82% (95% CI, 62–96%), respectively, in MCTA triplets. Conclusions Triplet pregnancies with TTTS are at high risk of adverse perinatal outcome and preterm birth, regardless of chorionicity. The rate of survival after FLP in MCTA triplets was higher in our study than that reported in previous studies and is currently comparable with